Global Choroidal Neovascularization Drug Market Growth 2024-2031

Report ID: 1503610 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Choroidal Neovascularization Drug Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Choroidal Neovascularization Drug by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Choroidal Neovascularization Drug by Country/Region, 2017, 2022 & 2028
    2.2 Choroidal Neovascularization Drug Segment by Type
        2.2.1 AVMOC-001
        2.2.2 BB-3
        2.2.3 BBT-007
        2.2.4 DG-3
        2.2.5 Entolimod
        2.2.6 EWA-001
        2.2.7 Others
    2.3 Choroidal Neovascularization Drug Sales by Type
        2.3.1 Global Choroidal Neovascularization Drug Sales Market Share by Type (2017-2022)
        2.3.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Choroidal Neovascularization Drug Sale Price by Type (2017-2022)
    2.4 Choroidal Neovascularization Drug Segment by Application
        2.4.1 Clinic
        2.4.2 Hospital
        2.4.3 Others
    2.5 Choroidal Neovascularization Drug Sales by Application
        2.5.1 Global Choroidal Neovascularization Drug Sale Market Share by Application (2017-2022)
        2.5.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Choroidal Neovascularization Drug Sale Price by Application (2017-2022)
3 Global Choroidal Neovascularization Drug by Company
    3.1 Global Choroidal Neovascularization Drug Breakdown Data by Company
        3.1.1 Global Choroidal Neovascularization Drug Annual Sales by Company (2020-2022)
        3.1.2 Global Choroidal Neovascularization Drug Sales Market Share by Company (2020-2022)
    3.2 Global Choroidal Neovascularization Drug Annual Revenue by Company (2020-2022)
        3.2.1 Global Choroidal Neovascularization Drug Revenue by Company (2020-2022)
        3.2.2 Global Choroidal Neovascularization Drug Revenue Market Share by Company (2020-2022)
    3.3 Global Choroidal Neovascularization Drug Sale Price by Company
    3.4 Key Manufacturers Choroidal Neovascularization Drug Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Choroidal Neovascularization Drug Product Location Distribution
        3.4.2 Players Choroidal Neovascularization Drug Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Choroidal Neovascularization Drug by Geographic Region
    4.1 World Historic Choroidal Neovascularization Drug Market Size by Geographic Region (2017-2022)
        4.1.1 Global Choroidal Neovascularization Drug Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Choroidal Neovascularization Drug Annual Revenue by Geographic Region
    4.2 World Historic Choroidal Neovascularization Drug Market Size by Country/Region (2017-2022)
        4.2.1 Global Choroidal Neovascularization Drug Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Choroidal Neovascularization Drug Annual Revenue by Country/Region
    4.3 Americas Choroidal Neovascularization Drug Sales Growth
    4.4 APAC Choroidal Neovascularization Drug Sales Growth
    4.5 Europe Choroidal Neovascularization Drug Sales Growth
    4.6 Middle East & Africa Choroidal Neovascularization Drug Sales Growth
5 Americas
    5.1 Americas Choroidal Neovascularization Drug Sales by Country
        5.1.1 Americas Choroidal Neovascularization Drug Sales by Country (2017-2022)
        5.1.2 Americas Choroidal Neovascularization Drug Revenue by Country (2017-2022)
    5.2 Americas Choroidal Neovascularization Drug Sales by Type
    5.3 Americas Choroidal Neovascularization Drug Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Choroidal Neovascularization Drug Sales by Region
        6.1.1 APAC Choroidal Neovascularization Drug Sales by Region (2017-2022)
        6.1.2 APAC Choroidal Neovascularization Drug Revenue by Region (2017-2022)
    6.2 APAC Choroidal Neovascularization Drug Sales by Type
    6.3 APAC Choroidal Neovascularization Drug Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Choroidal Neovascularization Drug by Country
        7.1.1 Europe Choroidal Neovascularization Drug Sales by Country (2017-2022)
        7.1.2 Europe Choroidal Neovascularization Drug Revenue by Country (2017-2022)
    7.2 Europe Choroidal Neovascularization Drug Sales by Type
    7.3 Europe Choroidal Neovascularization Drug Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Choroidal Neovascularization Drug by Country
        8.1.1 Middle East & Africa Choroidal Neovascularization Drug Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Choroidal Neovascularization Drug Revenue by Country (2017-2022)
    8.2 Middle East & Africa Choroidal Neovascularization Drug Sales by Type
    8.3 Middle East & Africa Choroidal Neovascularization Drug Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug
    10.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug
    10.4 Industry Chain Structure of Choroidal Neovascularization Drug
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Choroidal Neovascularization Drug Distributors
    11.3 Choroidal Neovascularization Drug Customer
12 World Forecast Review for Choroidal Neovascularization Drug by Geographic Region
    12.1 Global Choroidal Neovascularization Drug Market Size Forecast by Region
        12.1.1 Global Choroidal Neovascularization Drug Forecast by Region (2023-2028)
        12.1.2 Global Choroidal Neovascularization Drug Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Choroidal Neovascularization Drug Forecast by Type
    12.7 Global Choroidal Neovascularization Drug Forecast by Application
13 Key Players Analysis
    13.1 Cellphire, Inc.
        13.1.1 Cellphire, Inc. Company Information
        13.1.2 Cellphire, Inc. Choroidal Neovascularization Drug Product Offered
        13.1.3 Cellphire, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Cellphire, Inc. Main Business Overview
        13.1.5 Cellphire, Inc. Latest Developments
    13.2 Chrysalis BioTherapeutics, Inc.
        13.2.1 Chrysalis BioTherapeutics, Inc. Company Information
        13.2.2 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Product Offered
        13.2.3 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Chrysalis BioTherapeutics, Inc. Main Business Overview
        13.2.5 Chrysalis BioTherapeutics, Inc. Latest Developments
    13.3 Cleveland BioLabs, Inc.
        13.3.1 Cleveland BioLabs, Inc. Company Information
        13.3.2 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Product Offered
        13.3.3 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Cleveland BioLabs, Inc. Main Business Overview
        13.3.5 Cleveland BioLabs, Inc. Latest Developments
    13.4 Cumberland Pharmaceuticals, Inc.
        13.4.1 Cumberland Pharmaceuticals, Inc. Company Information
        13.4.2 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Product Offered
        13.4.3 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Cumberland Pharmaceuticals, Inc. Main Business Overview
        13.4.5 Cumberland Pharmaceuticals, Inc. Latest Developments
    13.5 Diffusion Pharmaceuticals Inc.
        13.5.1 Diffusion Pharmaceuticals Inc. Company Information
        13.5.2 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Product Offered
        13.5.3 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Diffusion Pharmaceuticals Inc. Main Business Overview
        13.5.5 Diffusion Pharmaceuticals Inc. Latest Developments
    13.6 Eli Lilly and Company
        13.6.1 Eli Lilly and Company Company Information
        13.6.2 Eli Lilly and Company Choroidal Neovascularization Drug Product Offered
        13.6.3 Eli Lilly and Company Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Eli Lilly and Company Main Business Overview
        13.6.5 Eli Lilly and Company Latest Developments
    13.7 GNI Group Ltd.
        13.7.1 GNI Group Ltd. Company Information
        13.7.2 GNI Group Ltd. Choroidal Neovascularization Drug Product Offered
        13.7.3 GNI Group Ltd. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 GNI Group Ltd. Main Business Overview
        13.7.5 GNI Group Ltd. Latest Developments
    13.8 Humanetics Corporation
        13.8.1 Humanetics Corporation Company Information
        13.8.2 Humanetics Corporation Choroidal Neovascularization Drug Product Offered
        13.8.3 Humanetics Corporation Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Humanetics Corporation Main Business Overview
        13.8.5 Humanetics Corporation Latest Developments
    13.9 INSYS Therapeutics, Inc.
        13.9.1 INSYS Therapeutics, Inc. Company Information
        13.9.2 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Product Offered
        13.9.3 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 INSYS Therapeutics, Inc. Main Business Overview
        13.9.5 INSYS Therapeutics, Inc. Latest Developments
    13.10 Meabco A/S
        13.10.1 Meabco A/S Company Information
        13.10.2 Meabco A/S Choroidal Neovascularization Drug Product Offered
        13.10.3 Meabco A/S Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Meabco A/S Main Business Overview
        13.10.5 Meabco A/S Latest Developments
    13.11 Neumedicines Inc.
        13.11.1 Neumedicines Inc. Company Information
        13.11.2 Neumedicines Inc. Choroidal Neovascularization Drug Product Offered
        13.11.3 Neumedicines Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Neumedicines Inc. Main Business Overview
        13.11.5 Neumedicines Inc. Latest Developments
    13.12 Onconova Therapeutics, Inc.
        13.12.1 Onconova Therapeutics, Inc. Company Information
        13.12.2 Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Product Offered
        13.12.3 Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Onconova Therapeutics, Inc. Main Business Overview
        13.12.5 Onconova Therapeutics, Inc. Latest Developments
    13.13 PharmaIN Corporation
        13.13.1 PharmaIN Corporation Company Information
        13.13.2 PharmaIN Corporation Choroidal Neovascularization Drug Product Offered
        13.13.3 PharmaIN Corporation Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 PharmaIN Corporation Main Business Overview
        13.13.5 PharmaIN Corporation Latest Developments
    13.14 Pluristem Therapeutics Inc.
        13.14.1 Pluristem Therapeutics Inc. Company Information
        13.14.2 Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Product Offered
        13.14.3 Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Pluristem Therapeutics Inc. Main Business Overview
        13.14.5 Pluristem Therapeutics Inc. Latest Developments
    13.15 ProCertus BioPharm Inc.
        13.15.1 ProCertus BioPharm Inc. Company Information
        13.15.2 ProCertus BioPharm Inc. Choroidal Neovascularization Drug Product Offered
        13.15.3 ProCertus BioPharm Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 ProCertus BioPharm Inc. Main Business Overview
        13.15.5 ProCertus BioPharm Inc. Latest Developments
    13.16 RDD Pharma Ltd.
        13.16.1 RDD Pharma Ltd. Company Information
        13.16.2 RDD Pharma Ltd. Choroidal Neovascularization Drug Product Offered
        13.16.3 RDD Pharma Ltd. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 RDD Pharma Ltd. Main Business Overview
        13.16.5 RDD Pharma Ltd. Latest Developments
    13.17 RedHill Biopharma Ltd.
        13.17.1 RedHill Biopharma Ltd. Company Information
        13.17.2 RedHill Biopharma Ltd. Choroidal Neovascularization Drug Product Offered
        13.17.3 RedHill Biopharma Ltd. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 RedHill Biopharma Ltd. Main Business Overview
        13.17.5 RedHill Biopharma Ltd. Latest Developments
    13.18 RxBio, Inc.
        13.18.1 RxBio, Inc. Company Information
        13.18.2 RxBio, Inc. Choroidal Neovascularization Drug Product Offered
        13.18.3 RxBio, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 RxBio, Inc. Main Business Overview
        13.18.5 RxBio, Inc. Latest Developments
    13.19 Soligenix, Inc.
        13.19.1 Soligenix, Inc. Company Information
        13.19.2 Soligenix, Inc. Choroidal Neovascularization Drug Product Offered
        13.19.3 Soligenix, Inc. Choroidal Neovascularization Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.19.4 Soligenix, Inc. Main Business Overview
        13.19.5 Soligenix, Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Choroidal Neovascularization Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Choroidal Neovascularization Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of AVMOC-001
    Table 4. Major Players of BB-3
    Table 5. Major Players of BBT-007
    Table 6. Major Players of DG-3
    Table 7. Major Players of Entolimod
    Table 8. Major Players of EWA-001
    Table 9. Major Players of Others
    Table 10. Global Choroidal Neovascularization Drug Sales by Type (2017-2022) & (K Pcs)
    Table 11. Global Choroidal Neovascularization Drug Sales Market Share by Type (2017-2022)
    Table 12. Global Choroidal Neovascularization Drug Revenue by Type (2017-2022) & ($ million)
    Table 13. Global Choroidal Neovascularization Drug Revenue Market Share by Type (2017-2022)
    Table 14. Global Choroidal Neovascularization Drug Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 15. Global Choroidal Neovascularization Drug Sales by Application (2017-2022) & (K Pcs)
    Table 16. Global Choroidal Neovascularization Drug Sales Market Share by Application (2017-2022)
    Table 17. Global Choroidal Neovascularization Drug Revenue by Application (2017-2022)
    Table 18. Global Choroidal Neovascularization Drug Revenue Market Share by Application (2017-2022)
    Table 19. Global Choroidal Neovascularization Drug Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 20. Global Choroidal Neovascularization Drug Sales by Company (2020-2022) & (K Pcs)
    Table 21. Global Choroidal Neovascularization Drug Sales Market Share by Company (2020-2022)
    Table 22. Global Choroidal Neovascularization Drug Revenue by Company (2020-2022) ($ Millions)
    Table 23. Global Choroidal Neovascularization Drug Revenue Market Share by Company (2020-2022)
    Table 24. Global Choroidal Neovascularization Drug Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 25. Key Manufacturers Choroidal Neovascularization Drug Producing Area Distribution and Sales Area
    Table 26. Players Choroidal Neovascularization Drug Products Offered
    Table 27. Choroidal Neovascularization Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 28. New Products and Potential Entrants
    Table 29. Mergers & Acquisitions, Expansion
    Table 30. Global Choroidal Neovascularization Drug Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 31. Global Choroidal Neovascularization Drug Sales Market Share Geographic Region (2017-2022)
    Table 32. Global Choroidal Neovascularization Drug Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 33. Global Choroidal Neovascularization Drug Revenue Market Share by Geographic Region (2017-2022)
    Table 34. Global Choroidal Neovascularization Drug Sales by Country/Region (2017-2022) & (K Pcs)
    Table 35. Global Choroidal Neovascularization Drug Sales Market Share by Country/Region (2017-2022)
    Table 36. Global Choroidal Neovascularization Drug Revenue by Country/Region (2017-2022) & ($ millions)
    Table 37. Global Choroidal Neovascularization Drug Revenue Market Share by Country/Region (2017-2022)
    Table 38. Americas Choroidal Neovascularization Drug Sales by Country (2017-2022) & (K Pcs)
    Table 39. Americas Choroidal Neovascularization Drug Sales Market Share by Country (2017-2022)
    Table 40. Americas Choroidal Neovascularization Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 41. Americas Choroidal Neovascularization Drug Revenue Market Share by Country (2017-2022)
    Table 42. Americas Choroidal Neovascularization Drug Sales by Type (2017-2022) & (K Pcs)
    Table 43. Americas Choroidal Neovascularization Drug Sales Market Share by Type (2017-2022)
    Table 44. Americas Choroidal Neovascularization Drug Sales by Application (2017-2022) & (K Pcs)
    Table 45. Americas Choroidal Neovascularization Drug Sales Market Share by Application (2017-2022)
    Table 46. APAC Choroidal Neovascularization Drug Sales by Region (2017-2022) & (K Pcs)
    Table 47. APAC Choroidal Neovascularization Drug Sales Market Share by Region (2017-2022)
    Table 48. APAC Choroidal Neovascularization Drug Revenue by Region (2017-2022) & ($ Millions)
    Table 49. APAC Choroidal Neovascularization Drug Revenue Market Share by Region (2017-2022)
    Table 50. APAC Choroidal Neovascularization Drug Sales by Type (2017-2022) & (K Pcs)
    Table 51. APAC Choroidal Neovascularization Drug Sales Market Share by Type (2017-2022)
    Table 52. APAC Choroidal Neovascularization Drug Sales by Application (2017-2022) & (K Pcs)
    Table 53. APAC Choroidal Neovascularization Drug Sales Market Share by Application (2017-2022)
    Table 54. Europe Choroidal Neovascularization Drug Sales by Country (2017-2022) & (K Pcs)
    Table 55. Europe Choroidal Neovascularization Drug Sales Market Share by Country (2017-2022)
    Table 56. Europe Choroidal Neovascularization Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 57. Europe Choroidal Neovascularization Drug Revenue Market Share by Country (2017-2022)
    Table 58. Europe Choroidal Neovascularization Drug Sales by Type (2017-2022) & (K Pcs)
    Table 59. Europe Choroidal Neovascularization Drug Sales Market Share by Type (2017-2022)
    Table 60. Europe Choroidal Neovascularization Drug Sales by Application (2017-2022) & (K Pcs)
    Table 61. Europe Choroidal Neovascularization Drug Sales Market Share by Application (2017-2022)
    Table 62. Middle East & Africa Choroidal Neovascularization Drug Sales by Country (2017-2022) & (K Pcs)
    Table 63. Middle East & Africa Choroidal Neovascularization Drug Sales Market Share by Country (2017-2022)
    Table 64. Middle East & Africa Choroidal Neovascularization Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 65. Middle East & Africa Choroidal Neovascularization Drug Revenue Market Share by Country (2017-2022)
    Table 66. Middle East & Africa Choroidal Neovascularization Drug Sales by Type (2017-2022) & (K Pcs)
    Table 67. Middle East & Africa Choroidal Neovascularization Drug Sales Market Share by Type (2017-2022)
    Table 68. Middle East & Africa Choroidal Neovascularization Drug Sales by Application (2017-2022) & (K Pcs)
    Table 69. Middle East & Africa Choroidal Neovascularization Drug Sales Market Share by Application (2017-2022)
    Table 70. Key Market Drivers & Growth Opportunities of Choroidal Neovascularization Drug
    Table 71. Key Market Challenges & Risks of Choroidal Neovascularization Drug
    Table 72. Key Industry Trends of Choroidal Neovascularization Drug
    Table 73. Choroidal Neovascularization Drug Raw Material
    Table 74. Key Suppliers of Raw Materials
    Table 75. Choroidal Neovascularization Drug Distributors List
    Table 76. Choroidal Neovascularization Drug Customer List
    Table 77. Global Choroidal Neovascularization Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 78. Global Choroidal Neovascularization Drug Sales Market Forecast by Region
    Table 79. Global Choroidal Neovascularization Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 81. Americas Choroidal Neovascularization Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 82. Americas Choroidal Neovascularization Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. APAC Choroidal Neovascularization Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 84. APAC Choroidal Neovascularization Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 85. Europe Choroidal Neovascularization Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 86. Europe Choroidal Neovascularization Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 87. Middle East & Africa Choroidal Neovascularization Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 88. Middle East & Africa Choroidal Neovascularization Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 89. Global Choroidal Neovascularization Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 90. Global Choroidal Neovascularization Drug Sales Market Share Forecast by Type (2023-2028)
    Table 91. Global Choroidal Neovascularization Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 92. Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 93. Global Choroidal Neovascularization Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 94. Global Choroidal Neovascularization Drug Sales Market Share Forecast by Application (2023-2028)
    Table 95. Global Choroidal Neovascularization Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 96. Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 97. Cellphire, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 98. Cellphire, Inc. Choroidal Neovascularization Drug Product Offered
    Table 99. Cellphire, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 100. Cellphire, Inc. Main Business
    Table 101. Cellphire, Inc. Latest Developments
    Table 102. Chrysalis BioTherapeutics, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 103. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Product Offered
    Table 104. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 105. Chrysalis BioTherapeutics, Inc. Main Business
    Table 106. Chrysalis BioTherapeutics, Inc. Latest Developments
    Table 107. Cleveland BioLabs, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 108. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Product Offered
    Table 109. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 110. Cleveland BioLabs, Inc. Main Business
    Table 111. Cleveland BioLabs, Inc. Latest Developments
    Table 112. Cumberland Pharmaceuticals, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 113. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Product Offered
    Table 114. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 115. Cumberland Pharmaceuticals, Inc. Main Business
    Table 116. Cumberland Pharmaceuticals, Inc. Latest Developments
    Table 117. Diffusion Pharmaceuticals Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 118. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Product Offered
    Table 119. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 120. Diffusion Pharmaceuticals Inc. Main Business
    Table 121. Diffusion Pharmaceuticals Inc. Latest Developments
    Table 122. Eli Lilly and Company Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 123. Eli Lilly and Company Choroidal Neovascularization Drug Product Offered
    Table 124. Eli Lilly and Company Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 125. Eli Lilly and Company Main Business
    Table 126. Eli Lilly and Company Latest Developments
    Table 127. GNI Group Ltd. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 128. GNI Group Ltd. Choroidal Neovascularization Drug Product Offered
    Table 129. GNI Group Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 130. GNI Group Ltd. Main Business
    Table 131. GNI Group Ltd. Latest Developments
    Table 132. Humanetics Corporation Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 133. Humanetics Corporation Choroidal Neovascularization Drug Product Offered
    Table 134. Humanetics Corporation Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 135. Humanetics Corporation Main Business
    Table 136. Humanetics Corporation Latest Developments
    Table 137. INSYS Therapeutics, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 138. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Product Offered
    Table 139. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 140. INSYS Therapeutics, Inc. Main Business
    Table 141. INSYS Therapeutics, Inc. Latest Developments
    Table 142. Meabco A/S Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 143. Meabco A/S Choroidal Neovascularization Drug Product Offered
    Table 144. Meabco A/S Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 145. Meabco A/S Main Business
    Table 146. Meabco A/S Latest Developments
    Table 147. Neumedicines Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 148. Neumedicines Inc. Choroidal Neovascularization Drug Product Offered
    Table 149. Neumedicines Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 150. Neumedicines Inc. Main Business
    Table 151. Neumedicines Inc. Latest Developments
    Table 152. Onconova Therapeutics, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 153. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Product Offered
    Table 154. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 155. Onconova Therapeutics, Inc. Main Business
    Table 156. Onconova Therapeutics, Inc. Latest Developments
    Table 157. PharmaIN Corporation Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 158. PharmaIN Corporation Choroidal Neovascularization Drug Product Offered
    Table 159. PharmaIN Corporation Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 160. PharmaIN Corporation Main Business
    Table 161. PharmaIN Corporation Latest Developments
    Table 162. Pluristem Therapeutics Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 163. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Product Offered
    Table 164. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 165. Pluristem Therapeutics Inc. Main Business
    Table 166. Pluristem Therapeutics Inc. Latest Developments
    Table 167. ProCertus BioPharm Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 168. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Product Offered
    Table 169. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 170. ProCertus BioPharm Inc. Main Business
    Table 171. ProCertus BioPharm Inc. Latest Developments
    Table 172. RDD Pharma Ltd. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 173. RDD Pharma Ltd. Choroidal Neovascularization Drug Product Offered
    Table 174. RDD Pharma Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 175. RDD Pharma Ltd. Main Business
    Table 176. RDD Pharma Ltd. Latest Developments
    Table 177. RedHill Biopharma Ltd. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 178. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Product Offered
    Table 179. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 180. RedHill Biopharma Ltd. Main Business
    Table 181. RedHill Biopharma Ltd. Latest Developments
    Table 182. RxBio, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 183. RxBio, Inc. Choroidal Neovascularization Drug Product Offered
    Table 184. RxBio, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 185. RxBio, Inc. Main Business
    Table 186. RxBio, Inc. Latest Developments
    Table 187. Soligenix, Inc. Basic Information, Choroidal Neovascularization Drug Manufacturing Base, Sales Area and Its Competitors
    Table 188. Soligenix, Inc. Choroidal Neovascularization Drug Product Offered
    Table 189. Soligenix, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 190. Soligenix, Inc. Main Business
    Table 191. Soligenix, Inc. Latest Developments
List of Figures
    Figure 1. Picture of Choroidal Neovascularization Drug
    Figure 2. Choroidal Neovascularization Drug Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Choroidal Neovascularization Drug Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Choroidal Neovascularization Drug Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Choroidal Neovascularization Drug Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of AVMOC-001
    Figure 10. Product Picture of BB-3
    Figure 11. Product Picture of BBT-007
    Figure 12. Product Picture of DG-3
    Figure 13. Product Picture of Entolimod
    Figure 14. Product Picture of EWA-001
    Figure 15. Product Picture of Others
    Figure 16. Global Choroidal Neovascularization Drug Sales Market Share by Type in 2021
    Figure 17. Global Choroidal Neovascularization Drug Revenue Market Share by Type (2017-2022)
    Figure 18. Choroidal Neovascularization Drug Consumed in Clinic
    Figure 19. Global Choroidal Neovascularization Drug Market: Clinic (2017-2022) & (K Pcs)
    Figure 20. Choroidal Neovascularization Drug Consumed in Hospital
    Figure 21. Global Choroidal Neovascularization Drug Market: Hospital (2017-2022) & (K Pcs)
    Figure 22. Choroidal Neovascularization Drug Consumed in Others
    Figure 23. Global Choroidal Neovascularization Drug Market: Others (2017-2022) & (K Pcs)
    Figure 24. Global Choroidal Neovascularization Drug Sales Market Share by Application (2017-2022)
    Figure 25. Global Choroidal Neovascularization Drug Revenue Market Share by Application in 2021
    Figure 26. Choroidal Neovascularization Drug Revenue Market by Company in 2021 ($ Million)
    Figure 27. Global Choroidal Neovascularization Drug Revenue Market Share by Company in 2021
    Figure 28. Global Choroidal Neovascularization Drug Sales Market Share by Geographic Region (2017-2022)
    Figure 29. Global Choroidal Neovascularization Drug Revenue Market Share by Geographic Region in 2021
    Figure 30. Global Choroidal Neovascularization Drug Sales Market Share by Region (2017-2022)
    Figure 31. Global Choroidal Neovascularization Drug Revenue Market Share by Country/Region in 2021
    Figure 32. Americas Choroidal Neovascularization Drug Sales 2017-2022 (K Pcs)
    Figure 33. Americas Choroidal Neovascularization Drug Revenue 2017-2022 ($ Millions)
    Figure 34. APAC Choroidal Neovascularization Drug Sales 2017-2022 (K Pcs)
    Figure 35. APAC Choroidal Neovascularization Drug Revenue 2017-2022 ($ Millions)
    Figure 36. Europe Choroidal Neovascularization Drug Sales 2017-2022 (K Pcs)
    Figure 37. Europe Choroidal Neovascularization Drug Revenue 2017-2022 ($ Millions)
    Figure 38. Middle East & Africa Choroidal Neovascularization Drug Sales 2017-2022 (K Pcs)
    Figure 39. Middle East & Africa Choroidal Neovascularization Drug Revenue 2017-2022 ($ Millions)
    Figure 40. Americas Choroidal Neovascularization Drug Sales Market Share by Country in 2021
    Figure 41. Americas Choroidal Neovascularization Drug Revenue Market Share by Country in 2021
    Figure 42. United States Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Canada Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Mexico Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Brazil Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 46. APAC Choroidal Neovascularization Drug Sales Market Share by Region in 2021
    Figure 47. APAC Choroidal Neovascularization Drug Revenue Market Share by Regions in 2021
    Figure 48. China Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Japan Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 50. South Korea Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Southeast Asia Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 52. India Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Australia Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Europe Choroidal Neovascularization Drug Sales Market Share by Country in 2021
    Figure 55. Europe Choroidal Neovascularization Drug Revenue Market Share by Country in 2021
    Figure 56. Germany Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 57. France Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 58. UK Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Italy Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Russia Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Middle East & Africa Choroidal Neovascularization Drug Sales Market Share by Country in 2021
    Figure 62. Middle East & Africa Choroidal Neovascularization Drug Revenue Market Share by Country in 2021
    Figure 63. Egypt Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 64. South Africa Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Israel Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Turkey Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 67. GCC Country Choroidal Neovascularization Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 68. Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug in 2021
    Figure 69. Manufacturing Process Analysis of Choroidal Neovascularization Drug
    Figure 70. Industry Chain Structure of Choroidal Neovascularization Drug
    Figure 71. Channels of Distribution
    Figure 72. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Choroidal Neovascularization Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Choroidal Neovascularization Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Choroidal Neovascularization Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports